Finance

Lists
BLISSGVS:NSE
Bliss GVS Pharma Ltd
₹653.00
-0.27%
(-1.75) 1D
Nov 11, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BLISSGVS...
Open
₹655.50
High
₹667.00
Low
₹633.00
Mkt. cap
70.60B
Avg. vol.
286.92K
Volume
124.09K
Dividend
0.23%
Quarterly dividend
₹0.37
Ex-dividend date
Jul 8, 2026
P/E ratio
43.89
52-wk high
₹739.90
52-wk low
₹140.80
EPS
₹14.88
Shares outstanding
103.15M
No. of employees
1K
Open
₹655.50
High
₹667.00
Low
₹633.00
Mkt. cap
70.60B
Avg. vol.
286.92K
Volume
124.09K
Dividend
0.23%
Quarterly dividend
₹0.37
Ex-dividend date
Jul 8, 2026
P/E ratio
43.89
52-wk high
₹739.90
52-wk low
₹140.80
EPS
₹14.88
Shares outstanding
103.15M
No. of employees
1K
News stories
From web sources and news partners
About Bliss GVS Pharma Ltd
CEO-
Employees1.03K
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Oct 29, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
3.13B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.18B
2.57B
2.86B
3.13B
Cost of goods sold
1.02B
1.36B
1.14B
1.19B
Cost of revenue
1.02B
1.36B
1.14B
1.19B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
359.36M
1.00B
430.47M
449.92M
Operating expense
901.49M
844.80M
1.05B
1.24B
Total operating expenses
1.92B
2.21B
2.19B
2.43B
Operating income
264.40M
363.12M
664.63M
700.89M
Other non operating income
184.56M
-597.23M
96.00M
83.05M
EBT including unusual items
408.96M
449.50M
754.83M
750.98M
EBT excluding unusual items
434.09M
431.08M
754.83M
750.98M
Income tax expense
161.17M
79.51M
241.11M
217.56M
Effective tax rate
39.41%
17.69%
31.94%
28.97%
Other operating expenses
458.64M
-244.91M
516.84M
683.33M
Net income
232.66M
355.75M
500.97M
522.52M
Net profit margin
10.66%
13.84%
17.54%
16.67%
Earnings per share
-
-
-
-
Interest and investment income
-
167.47M
-
-
Interest expense
-14.86M
-20.08M
-5.79M
-32.96M
Net interest expenses
-14.86M
147.40M
-5.79M
-32.96M
Depreciation and amortization charges
83.50M
86.71M
99.38M
104.96M
EBITDA
326.86M
431.12M
732.63M
803.06M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps